loader

World Tenders & Procurement Opportunities

133159- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-34 - Eculizumab

World Biggest Tenders Source

This tender with title 133159- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-34 - Eculizumab has been published on Bidding Source portal dated 16 Mar 2026 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

133159- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-34 - Eculizumab
Invitation for Bids
133159
Germany
16 Mar 2026
31 Mar 2026
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

133422- Germany – Pharmaceutical products – Open-House-Biologics-Rebate Agreements 2026-03b - Eculizumab (incl. the indication gMG and NMOSD) Germany Awarded - 133782- Germany – Pharmaceutical products – Announcement of awarded contracts pursuant to Section 130c of the German Social Code, Book V (SGB V) for the medicinal product Metformin / Dapagliflozin (Xigduo) Germany Awarded - 131795- Germany – Pharmaceutical products – Announcement of awarded contracts pursuant to Section 130c of the German Social Code, Book V (SGB V) for the medicinal product Inclisiran (Leqvio) Germany 132076- Germany – Pharmaceutical products – Open-House-Biologics-Rebate Agreements 2026-03a - Eculizumab (excluding the indication gMG and NMOSD) Germany Awarded - 131852- Germany – Pharmaceutical products – Announcement of awarded contracts pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient Tegomil fumarate (Riulvy) Germany Awarded - 130186- Germany – Pharmaceutical products – Drug contracts awarded on 01.01.2026 and 01.07.2026 Germany 128821- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the aforementioned active ingredients, with the option of concluding such agreements within the framework of the so-called open-house procedure. Germany 126159- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient nintedanib (ATC code: L01EX09). Germany 124866- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the aforementioned active ingredients, with the option of concluding such agreements within the framework of the so-called open-house procedure. Germany 124794- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (open-house procedure) Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans